The SsdC mutant is defective in both germination and heat-resistance. by Johana Luhur (9767765)

Image_2_WDHD1 Leads to Cisplatin Resistance by Promoting MAPRE2 Ubiquitination in Lung Adenocarcinoma.TIF by Lian Gong (8594868)

Image_1_WDHD1 Leads to Cisplatin Resistance by Promoting MAPRE2 Ubiquitination in Lung Adenocarcinoma.TIF by Lian Gong (8594868)

Image_3_WDHD1 Leads to Cisplatin Resistance by Promoting MAPRE2 Ubiquitination in Lung Adenocarcinoma.TIF by Lian Gong (8594868)

Table_1_Generation of Two Paclitaxel-Resistant High-Grade Serous Carcinoma Cell Lines With Increased Expression of P-Glycoprotein.xlsx by Mariana Nunes (6066908)

Image_1_Generation of Two Paclitaxel-Resistant High-Grade Serous Carcinoma Cell Lines With Increased Expression of P-Glycoprotein.pdf by Mariana Nunes (6066908)

Image_1_Generation of Two Paclitaxel-Resistant High-Grade Serous Carcinoma Cell Lines With Increased Expression of P-Glycoprotein.pdf by Mariana Nunes (6066908)

Table_1_Generation of Two Paclitaxel-Resistant High-Grade Serous Carcinoma Cell Lines With Increased Expression of P-Glycoprotein.xlsx by Mariana Nunes (6066908)

The proportion of drug-sensitive cells for increasing values of the sensitive cell death rate. by Tyler Cassidy (8052584)

Subjects:

DataSheet_1_Clonal evolution in tyrosine kinase inhibitor-resistance: lessons from in vitro-models.pdf by Meike Kaehler (4561306)

“…</p>Results<p>In this model, acquired sequence variants in NRAS, KRAS, PTPN11, and PDGFRB were identified in TKI resistance. The well-known pathogenic NRAS p.(Gln61Lys) variant provided a strong benefit for CML cells under TKI exposure visible by increased cell number (6.2-fold, p < 0.001) and decreased apoptosis (-25%, p < 0.001), proving the functionality of our approach. …”

DataSheet_1_PARP Inhibition Activates STAT3 in Both Tumor and Immune Cells Underlying Therapy Resistance and Immunosuppression In Ovarian Cancer.pdf by Antons Martincuks (11800829)

“…Finally, we demonstrate that the acquisition of PARPi resistance in ovarian cancer cells was accompanied by increased STAT3 activity. …”

DataSheet_1_PARP Inhibition Activates STAT3 in Both Tumor and Immune Cells Underlying Therapy Resistance and Immunosuppression In Ovarian Cancer.pdf by Antons Martincuks (11800829)

“…Finally, we demonstrate that the acquisition of PARPi resistance in ovarian cancer cells was accompanied by increased STAT3 activity. …”

Data_Sheet_1_Insulin Modulates the Immune Cell Phenotype in Pulmonary Allergic Inflammation and Increases Pulmonary Resistance in Diabetic Mice.pdf by Sabrina S. Ferreira (8432574)

Table_1_Increased AR expression in castration-resistant prostate cancer rapidly induces AR signaling reprogramming with the collaboration of EZH2.xlsx by Maryam Labaf (14049729)

RGC-32 expression increases cell proliferation in ER⁺ breast cancer cells. by Xinlei Li (243372)

Figure S4 from Exome Sequencing of Plasma DNA Portrays the Mutation Landscape of Colorectal Cancer and Discovers Mutated VEGFR2 Receptors as Modulators of Antiangiogenic Therapies by Rodrigo A. Toledo (14996709)

Rapamycin treatment-induced increased TGM2 is autophagy dependent. by Jingwen Cao (1806958)

MET knockdown decreases EGFR activation and does not influence EGFR expression. by Karolin Ebert (7434713)

Data_Sheet_2_WDHD1 Leads to Cisplatin Resistance by Promoting MAPRE2 Ubiquitination in Lung Adenocarcinoma.pdf by Lian Gong (8594868)

Data_Sheet_1_WDHD1 Leads to Cisplatin Resistance by Promoting MAPRE2 Ubiquitination in Lung Adenocarcinoma.pdf by Lian Gong (8594868)